Form 10-Q, quarterly report
enGene Therapeutics Inc., 10-Q filed 2026-09-08
Published 8 Sep 2026 · retrieved 9 Sep 2026, 02:30 EDT · version 1Official source
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
¶1
10-Q filed with the Securities and Exchange Commission by enGene Therapeutics Inc. (CIK 0001980845) on 2026-09-08.
¶2
Accession number 0001193125-26-384383. EDGAR reports the filing package as 13 MB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1980845/000119312526384383/0001193125-26-384383-index.htm.